1. Home
  2. TLX vs NWE Comparison

TLX vs NWE Comparison

Compare TLX & NWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • NWE
  • Stock Information
  • Founded
  • TLX 2015
  • NWE 1923
  • Country
  • TLX Australia
  • NWE United States
  • Employees
  • TLX N/A
  • NWE N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • NWE Power Generation
  • Sector
  • TLX Health Care
  • NWE Utilities
  • Exchange
  • TLX Nasdaq
  • NWE Nasdaq
  • Market Cap
  • TLX 3.2B
  • NWE 3.5B
  • IPO Year
  • TLX N/A
  • NWE N/A
  • Fundamental
  • Price
  • TLX $9.38
  • NWE $55.90
  • Analyst Decision
  • TLX Strong Buy
  • NWE Buy
  • Analyst Count
  • TLX 3
  • NWE 7
  • Target Price
  • TLX $21.33
  • NWE $60.00
  • AVG Volume (30 Days)
  • TLX 257.4K
  • NWE 416.5K
  • Earning Date
  • TLX 01-01-0001
  • NWE 10-27-2025
  • Dividend Yield
  • TLX N/A
  • NWE 4.71%
  • EPS Growth
  • TLX N/A
  • NWE 7.14
  • EPS
  • TLX 0.04
  • NWE 3.67
  • Revenue
  • TLX $664,225,558.00
  • NWE $1,527,970,000.00
  • Revenue This Year
  • TLX N/A
  • NWE $6.15
  • Revenue Next Year
  • TLX N/A
  • NWE $4.73
  • P/E Ratio
  • TLX $220.22
  • NWE $15.28
  • Revenue Growth
  • TLX 55.35
  • NWE 3.78
  • 52 Week Low
  • TLX $8.93
  • NWE $50.43
  • 52 Week High
  • TLX $30.36
  • NWE $59.89
  • Technical
  • Relative Strength Index (RSI)
  • TLX 36.10
  • NWE 46.32
  • Support Level
  • TLX $9.14
  • NWE $55.50
  • Resistance Level
  • TLX $9.53
  • NWE $57.44
  • Average True Range (ATR)
  • TLX 0.24
  • NWE 0.80
  • MACD
  • TLX 0.10
  • NWE -0.33
  • Stochastic Oscillator
  • TLX 25.71
  • NWE 14.71

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About NWE NorthWestern Energy Group Inc.

NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.

Share on Social Networks: